ArticleAmerican journal of cancer research2025

Effects of SGLT2 inhibitors and GLP-1 receptor agonists on glycemic variability, islet cell function, and insulin resistance in patients with type 2 diabetes mellitus and renal cell carcinoma.

Anqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.